In Acute Myeloid Leukemia Diagnosed Recently, FLT3 Inhibitor Is Very Effective.

Published Date: 16 Feb 2024

With crenolanib, the complete response rate was 86%, and the median event-free survival was almost four years.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Mutation Correlates with a Higher Prostate Cancer Mortality Risk.

2.

Big Comeback for Myeloma Drug; DIY Cancer Therapy; Gut Clues to Bladder Cancer

3.

Targeted Combination Shows Promise in Metastatic Kidney Cancer

4.

The Kansas Cancer Center awarded two Indian American doctors professorships.

5.

Firefighters who eat better can combat cancer.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot